Standard BioTools Inc. (LAB)

Standard BioTools Revenue

Standard BioTools had revenue of $126.76M in the twelve months ending March 31, 2024, with 31.27% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $45.54M with 81.30% year-over-year growth. In the year 2023, Standard BioTools had annual revenue of $106.34M with 8.57% growth.

• Revenue (ttm): $126.76M
• Revenue Growth: +31.27%
• P/S Ratio: 6.40
• Revenue / Employee: $235,178
• Employees: 539
• Market Cap: 811.22M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	106.34M	8.39M	8.57%
Dec 31, 2022	97.95M	-32.63M	-24.99%
Dec 31, 2021	130.58M	-7.56M	-5.47%
Dec 31, 2020	138.14M	20.90M	17.83%
Dec 31, 2019	117.24M	4.28M	3.79%
Dec 31, 2018	112.96M	11.03M	10.82%
Dec 31, 2017	101.94M	-2.51M	-2.40%
Dec 31, 2016	104.45M	-10.27M	-8.95%
Dec 31, 2015	114.71M	-1.74M	-1.50%
Dec 31, 2014	116.46M	45.27M	63.60%
Dec 31, 2013	71.18M	18.85M	36.02%
Dec 31, 2012	52.33M	9.47M	22.09%
Dec 31, 2011	42.87M	9.31M	27.73%
Dec 31, 2010	33.56M	8.15M	32.06%
Dec 31, 2009	25.41M	10.07M	65.58%
Dec 27, 2008	15.35M	8.07M	110.96%
Dec 29, 2007	7.28M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.